Latest Thalidomide Stories
BioPlus Specialty Pharmacy, one of the nationâ€™s leading specialty pharmacies, offers numerous oncology drugs as well as an oncology therapy management program that increases patient compliance. Altamonte Springs, FL (PRWEB) June 13, 2011 BioPlus Specialty Pharmacy (BioPlus), one of the nationâ€™s leading specialty pharmacies, has numerous oral oncology medications available for patients with cancer.
INDIANAPOLIS, May 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.
New research in the FASEB Journal details the first evidence that breakdown products of thalidomide produce the specific, toxic effects of thalidomide in embryos.
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma (HCC), according to data presented at the International Liver CongressTM 2011.
UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.
In the news release, Onyx Pharmaceuticals Announces Positive Complete Results From Carfilzomib Phase 2b Study, issued 07-Dec-2010 by Onyx Pharmaceuticals, Inc.
EMERYVILLE, Calif., Dec. 7, 2010 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.
BURLINGTON, Mass., Dec.
WHITE PLAINS, N.Y. and CHAPPAQUA, N.Y., Nov. 30, 2010 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and BioTheryX, Inc.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.